Short-Term Outcomes of the Calcineurin Inhibitor Avoidance Maintenance Regimen with Everolimus in Kidney Transplant Recipients.

被引:0
|
作者
Kutsunai, K. [1 ]
Iwadoh, K. [1 ]
Horibe, T. [1 ]
Ogawa, Y. [1 ]
Kai, K. [1 ]
Murakami, T. [1 ]
Koyama, I. [1 ]
Nakajima, I. [1 ]
Fuchinoue, S. [1 ]
机构
[1] Tokyo Womens Med Univ, Dept Surg, Kidney Ctr, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:316 / 316
页数:1
相关论文
共 50 条
  • [1] Experience With Everolimus Following Calcineurin Inhibitor Withdrawal in Liver Transplant Recipients.
    Fischer, L.
    Fung, J.
    Metselaar, H.
    Kaiser, G.
    Schemmer, P.
    Neuhaus, P.
    Dong, G.
    Junge, G.
    Schlitt, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 714 - 715
  • [2] Experience With Everolimus Following Calcineurin Inhibitor Withdrawal in Liver Transplant Recipients.
    Fischer, L.
    Fung, J.
    Metselaar, H.
    Kaiser, G.
    Schemmer, P.
    Neuhaus, P.
    Dong, G.
    Junge, G.
    Schlitt, H.
    TRANSPLANTATION, 2014, 98 : 714 - 715
  • [3] The TRANSFORM Study: Infection Outcomes with Everolimus Plus Reduced Calcineurin Inhibitor and Mycophenolate Plus Standard Calcineurin Inhibitor Regimens in De Novo Kidney Transplant Recipients.
    Vincenti, F.
    Cruzado, J.
    Mulgaonkar, S.
    Garcia, V.
    Kuypers, D.
    Buchler, M.
    Citterio, F.
    Huynh-Do, U.
    Luo, W-L.
    Bernhardt, P.
    Sommerer, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 258 - 258
  • [4] Sotrastaurin in Calcineurin Inhibitor-Free Regimen Using Everolimus in De Novo Kidney Transplant Recipients
    Tedesco-Silva, H.
    Kho, M. M. L.
    Hartmann, A.
    Vitko, S.
    Russ, G.
    Rostaing, L.
    Budde, K.
    Campistol, J. M.
    Eris, J.
    Krishnan, I.
    Gopalakrishnan, U.
    Klupp, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (07) : 1757 - 1768
  • [5] Unexpected Early Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients.
    Yanik, M.
    Mannon, R.
    Seifert, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 750 - 750
  • [6] Calcineurin Inhibitor Dosing Requirements in HIV Positive Kidney Transplant Recipients.
    Sievers, Theodore M.
    Emami, Sina
    Wilkinson, Alan
    Danovitch, Gabriel
    Pham, Phuong-Thu
    Bunnapradist, Suphamai
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 398 - 398
  • [7] TOLERABILITY OF EVEROLIMUS IN MAINTENANCE LIVER TRANSPLANT RECIPIENTS.
    Dumortier, Jerome
    Guillaud, Oliver
    Adham, Mustapha
    Gagnieu, Marie-Claude
    Boillot, Oliver
    LIVER TRANSPLANTATION, 2008, 14 (07) : S108 - S108
  • [8] CALCINEURIN INHIBITOR WITHDRAWAL IN THE PRESENCE OF EVEROLIMUS IS FEASIBLE IN MAINTENANCE LIVER TRANSPLANT RECIPIENTS
    Fischer, Lutz
    De Simone, Paolo
    Nevens, Frederik
    Metselaat, Herold J.
    Dumortier, Jerome
    Duvoux, Christophe
    Boudjema, Karim
    Le Treut, Yves Patrice
    Sterneck, Martina R.
    HEPATOLOGY, 2008, 48 (04) : 566A - 566A
  • [9] Calcineurin inhibitor free immunosuppression with everolimus and MMF in maintenance therapy of long term heart transplant recipients
    Vollenbroeker, Beate
    Stypmann, Joerg
    Langer, Claus
    Schmid, Christof
    Suwelack, Barbara
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 203 - 203
  • [10] Disparities in short-term outcomes between bridged to heart transplant recipients and nonbridged recipients.
    Gonzalez-Stawinski, GV
    Cook, DJ
    Chang, ASY
    Banbury, M
    Navia, JL
    Hoercher, K
    O' Taylor, D
    Yamani, MM
    Lober, C
    Young, JB
    Hobbs, RE
    Starling, R
    Smedira, NG
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 406 - 406